United States Infectious Disease Biomarker Testing Market By Product (Assays, Platforms), By Application (Respiratory Infection, Sexually Transmitted Infection, Bloodstream and Hospital-Acquired Infection, Urinary Tract Infection, Gastro-Intestinal Infection, Central Nervous System Infection, Others), By Technology (PCR, NGS, ELISA or EIA, IHC, ISH, Others), By Pathogen (Virus, Bacteria), By End U

United States infectious disease biomarker testing market is expected to witness double digit CAGR during the forecast period. Key factors propelling the growth of United States infectious disease biomarker testing market include

United States infectious disease biomarker testing market can be categorized based on

Based on end user, United States infectious disease biomarker testing market can be segmented into hospitals and clinics, diagnostic centers, research laboratories and others. Among them, hospitals and clinics segment are anticipated to undergo high growth in terms of revenue through 2027 as they have laboratories equipped with fully automated diagnostic instruments including NGS and PCR for providing better medical diagnostic results.

Major players operating in the United States infectious disease biomarker testing market include Abbott Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Hologic, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Hoffmann-La Roche Inc., Quest Diagnostics Incorporated and Qiagen Sciences, Inc., among others. The market players are undergoing partnerships and alliances to strengthen their business position in United States.

Objective of the Study

• To analyze and estimate the market size of United States infectious disease biomarker testing market from 2017 to 2020.
• To estimate and forecast the market size of United States infectious disease biomarker testing market from 2021 to 2027 and growth rate until 2027.
• to classify and forecast United States infectious disease biomarker testing market based on product, application, technology, pathogen, end user, company and regional distribution.
• To identify dominant region or segment in the United States infectious disease biomarker testing market.
• To identify drivers and challenges for United States infectious disease biomarker testing market.
• To examine competitive developments such as expansions, mergers & acquisitions, etc., in United States infectious disease biomarker testing market.
• To conduct pricing analysis for United States infectious disease biomarker testing market.
• To identify and analyze the profile of leading players operating in United States infectious disease biomarker testing market.
• To identify key sustainable strategies adopted by market players in United States infectious disease biomarker testing market.

Click here to download the sample

Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of infectious disease biomarker testing system manufacturers across United States. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the manufacturers who could not be identified due to the limitations of secondary research. Market insights research analyzed the presence of all major players across United States.

Market insights research calculated the market size of

Key Target Audience

• Infectious disease biomarker testing system manufacturers, suppliers, distributors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to infectious disease biomarker testing
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as